Rentokil Initial (RTO) Stock Price, News & Analysis

Company Overview

Rentokil Initial plc (NYSE:RTO) is a global business services company specializing in pest control, hygiene and workwear solutions. Originating in 1925 when entomologist Harold Maxwell‐Lefroy pioneered chemical treatments for insect pests, the firm expanded through a series of strategic mergers and acquisitions, most notably the 1996 combination of Rentokil and Initial. Today, Rentokil Initial operates as a leading provider of essential services designed to protect health, property and reputations across diverse customer segments.

The company’s core pest control division offers comprehensive prevention and treatment services for rodents, insects, birds and other pests in residential, commercial and industrial environments. Its hygiene arm supplies washroom hygiene systems, infection control products and hand hygiene consumables, helping organizations maintain clean and safe facilities. In addition, the workwear division provides uniform rental, laundering and personal protective equipment tailored to sectors such as hospitality, healthcare and manufacturing.

With operations in more than 80 countries, Rentokil Initial serves markets across North America, Europe, Asia‐Pacific, Latin America and the Middle East. The company has built a strong presence through organic growth and targeted acquisitions, including notable expansions in the United States and Australia. Local service branches and regional hubs enable it to deliver scalable solutions while maintaining responsiveness to local regulations and industry standards.

Governed by a board of directors and led by Chief Executive Officer Andy Ransom, Rentokil Initial emphasizes sustainability, innovation and customer service excellence. The executive leadership team oversees a global network of technicians, field operatives and support staff, investing in digital technologies and training programs to drive operational efficiency and enhance client satisfaction.

Key Stats

• Today's Range: $22.72 to $23.05
• 50-Day Range: $22.89 to $24.43
• 52-Week Range: $19.60 to $34.07
• Volume: 650,318 shs
• Average Volume: 790,028 shs
• Market Capitalization: $11.57 billion
• P/E Ratio: 15.17
• Dividend Yield: 3.01%
• Price Target: N/A
• Consensus Rating: Moderate Buy

Rentokil Initial Stock Analysis - MarketRank™

Rentokil Initial scored higher than 35% of companies evaluated by MarketBeat, and ranked 212th out of 303 stocks in the business services sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Rentokil Initial.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 6.02%

Earnings Growth

Earnings for Rentokil Initial are expected to grow by 6.02% in the coming year, from $1.33 to $1.41 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Rentokil Initial is 15.18, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 25.91.

Price to Earnings Ratio vs. Sector

The P/E ratio of Rentokil Initial is 15.18, which means that it is trading at a less expensive P/E ratio than the Business Services sector average P/E ratio of about 28.83.

Price to Book Value per Share Ratio

Rentokil Initial has a P/B Ratio of 2.14. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.31% of the float of Rentokil Initial has been sold short.

Short Interest Ratio / Days to Cover

Rentokil Initial has a short interest ratio ("days to cover") of 1.9, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Rentokil Initial has recently increased by 33.33%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 2.5 / 5
• Dividend Strength: Moderate

Dividend Yield

Rentokil Initial pays a meaningful dividend of 2.89%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Rentokil Initial does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Rentokil Initial is 45.70%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, Rentokil Initial will have a dividend payout ratio of 48.94% next year. This indicates that Rentokil Initial will be able to sustain or increase its dividend.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

0.31% of the float of Rentokil Initial has been sold short.

Short Interest Ratio / Days to Cover

Rentokil Initial has a short interest ratio ("days to cover") of 1.9, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Rentokil Initial has recently increased by 33.33%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 1.5 / 5
• News Sentiment: 0.67

News Sentiment

Rentokil Initial has a news sentiment score of 0.67. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Business Services companies.

News Coverage This Week

MarketBeat has tracked 6 news articles for Rentokil Initial this week, compared to 9 articles on an average week.

MarketBeat Follows

Only 1 people have added Rentokil Initial to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Rentokil Initial insiders have not sold or bought any company stock.

Percentage Held by Institutions

Only 9.91% of the stock of Rentokil Initial is held by institutions.

RTO Stock Analysis - Frequently Asked Questions

How have RTO shares performed this year?

Rentokil Initial's stock was trading at $25.32 at the beginning of the year. Since then, RTO stock has decreased by 9.5% and is now trading at $22.91.

How were Rentokil Initial's earnings last quarter?

Rentokil Initial PLC (NYSE:RTO) announced its quarterly earnings results on Thursday, August, 6th. The company reported $0.40 earnings per share for the quarter, beating the consensus estimate of $0.36 by $0.04. The company's revenue was down 4.6% compared to the same quarter last year.
Read the conference call transcript.

Who are Rentokil Initial's major shareholders?

Rentokil Initial's top institutional shareholders include Veracity Capital LLC and Parallel Advisors LLC.
View institutional ownership trends.

How do I buy shares of Rentokil Initial?

Shares of RTO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Rentokil Initial own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Rentokil Initial investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), Advanced Micro Devices (AMD), ServiceNow (NOW), Adobe (ADBE) and GE Aerospace (GE).

Company Calendar

• Last Earnings: 8/06/2020
• Record date for 5/15 Dividend: 4/04/2025
• Ex-Dividend for 5/15 Dividend: 4/04/2025
• Dividend Payable: 5/15/2025
• Today: 7/09/2025
• Next Earnings (Estimated): 7/31/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Business Services
• Industry: BUSINESS SVCS
• Sub-Industry: Business Services
• Current Symbol: NYSE:RTO
• CIK: 930157
• Web: www.rentokil-initial.com
• Phone: 441293858000
• Fax: N/A
• Employees: 68,485
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 15.10
• Forward P/E Ratio: 17.15
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 0.59
• Current Ratio: 0.81
• Quick Ratio: 0.72

Sales & Book Value

• Annual Sales: $6.95 billion
• Price / Sales: 1.66
• Cash Flow: $2.47 per share
• Price / Cash Flow: 9.24
• Book Value: $10.70 per share
• Price / Book: 2.13

Miscellaneous

• Outstanding Shares: 504,910,000
• Free Float: N/A
• Market Cap: $11.51 billion
• Optionable: Not Optionable
• Beta: 0.94